The unexpected move by Advanced Medical Optics Inc. (AMO) to acquire VISX Inc. in a $1.27 billion cash and stock deal caught Wall Street-and many in the ophthalmic industry-by complete surprise.
Myze launches platform to engage 1 million dry eye patients by 2025: How Do Your Eyes Feel?
More ocular symptoms found in smokers who used cigarettes than e-cigarettes
COVID-19-imposed health care restrictions had no negative effects on status of DME
